AC8 0.00% 4.0¢ auscann group holdings ltd

Ann: AusCann Releases Low-dose Form Capsule, page-43

  1. 917 Posts.
    lightbulb Created with Sketch. 275
    the approach AC8 is taking is absolutely correct, best standards, clinical research, product development measured against real problems and done in collaboration with the healthcare professionals. They just need to get on with it and realise life doesn’t stop with a hard shell capsule, clinical evaluation and product development now !!!
    this is the way to go and I am going to support this approach , back to buy from held for me .
 
watchlist Created with Sketch. Add AC8 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.